Neuphoria Therapeutics Inc. Revenue 2025–2025
Neuphoria Therapeutics Inc. annual/quarterly revenue history and growth rate from 2025 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Neuphoria Therapeutics Inc. revenue for the quarter ending March 31, 2025 was 15.0 M.
- Neuphoria Therapeutics Inc. annual revenue for 2025 was 15.6 M.
Neuphoria Therapeutics Inc. (NEUP) — Frequently Asked Questions
Neuphoria Therapeutics Inc. (NEUP) is a publicly traded US company. It has a market capitalization of $7M. In fiscal 2025 it reported revenue of $16M and net income of -$369,632. Explore NEUP's stock price, financial statements, earnings history, margins and key ratios below.
What is Neuphoria Therapeutics Inc.'s market cap?
Neuphoria Therapeutics Inc. (NEUP) has a market capitalization of $7M.
What is the NEUP stock price?
NEUP trades at $4.49 (+1.58% on the day).
How much revenue does Neuphoria Therapeutics Inc. make?
Neuphoria Therapeutics Inc. reported revenue of $16M in fiscal 2025.
Is NEUP profitable?
In fiscal 2025, Neuphoria Therapeutics Inc. reported net income of -$369,632.